The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Safe biotechnology (5). Recommendations for safe work with animal and human cell cultures concerning potential human pathogens
Abstract
The benefits of using animal or human cell cultures have been clearly demonstrated in diagnostic and therapeutic research and in their application for manufacturing. Cell cultures serve as a tools for the production of vaccines, receptors, enzymes, monoclonal antibodies and recombinant DNA-derived proteins. They represent an integral part of drug development for which corresponding facilities, equipment and manufacturing processes are required. Although the cells themselves offer no particular risk to workers in laboratories and production areas or to the environment, the cell cultures may be contaminated with viruses, mycoplasma, bacteria, yeast and fungi or might contain endogenous viruses. The containment level for animal and human cells is therefore determined by the risk class of these agents. The history of animal and human cell cultures has proved that they can be handled safely. The recommendations in this publication concern the safe handling of cell cultures (tissue explants, primary cell cultures) and permanent cell lines of animal and human origin. A classification system of safety precautions has been elaborated according to the potential for contamination with the pathogenic agents involved.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For all sources of cells, the availability of data from microbiological screening tests will help mitigate risk”
From Guidance document on Good cell and tissue culture practice 2.0 (GCCP 2.0) (2021) · cites this paper as Frommer et al., 1993
In the citing paper
“the culture and storage history may be useful in flagging potential hazards from reagents and costored materials (Frommer et al., 1993; Fountain et al., 1997).”
From Guidance document on Good cell and tissue culture practice 2.0 (GCCP 2.0) (2021) · cites this paper as Frommer et al., 1993
Citations
Cites
World Health Organization Technical Report Series
(1972) · Journal of AOAC INTERNATIONAL · doi:10.1093/jaoac/55.3.666 · Cited by 917
Guidelines for Research Involving Recombinant DNA Molecules
Malcolm, S. (1978) · Journal of Medical Genetics · doi:10.1136/jmg.15.4.324 · Cited by 133
Needle-Stick Transmission of Human Colonic Adenocarcinoma
Gugel, E. A., & Sanders, M. E. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612043152314 · Cited by 55
Frommer, W., Ager, B. P., Archer, L., Brunius, G., Collins, C. H., Donikian, R., Frontali, C., Hamp, S., Houwink, E. H., Küenzi, M. T., et al. (1989) · Applied Microbiology and Biotechnology · doi:10.1007/bf00255357 · Cited by 46
Self-citationOperator-induced contamination in cell culture systems.
Hay, R. J. (1991) · PubMed · Cited by 35
Line Cell Saga — An Argument in Favor of Production of Biologics in Cancer Cells
Hilleman, M. R. (1979) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-0997-0_6 · Cited by 17
A new agricultural system for Europe?
Munck, L. (1987) · Trends in biotechnology · doi:10.1016/0167-7799(87)90063-1 · Cited by 15
(1987) · PubMed · Cited by 14
Research works printed but not linked: 8
- BMFT (1986) Richtlinien zum Schutz vor Gefahren durch in vitro neukombinierte Nukleinsäuren. 5. überarbeitete Fassung, Bundesanzeiger Verlagsgesellschaft mbH, Köln
- CEC (1988) Committee for Proprietary Medicinal Products / Ad Hoc Working Party on Biotechnology / Pharmacy, Commission of the European Community. Guidelines on the production and quality control of monoclonal antibodies of murine origin intended for use in man. Trends in Biotechnology 6, G5-G8
- Directive 90/219/EEC. Council Directive of 23 April 1990 on the contained use of genetically modified microorganisms (90/219/EEC). Official Journal of the European Communities No. L117/1, May 8, 1990
- Directive 90/679/EEC. Council Directive of 26 November 1990 on the protection of workers from risks related to exposure to biological agents at work (seventh individual Directive within the meaning of articlae 16 (1) of directive 89/391/EEC (90/679/EEC)). Official Journal of the European Communities No. L376/1, December 31, 1990
- FDA Guidelines (1987a) Points to consider in the manufacture of monoclonal antibody products for human use. CBER, US Food and Drug Administration, Bethesda, MD
- FDA Guidelines (1987b) Points to consider in the characterisation of cell lines used to produce biologicals. CBER, US Food and Drug Administration, Bethesda, MD
- Johannsen R, Albert W, Hunsmann G, Krämer P, Noé W, Schirrmacher V, Schlumberger H-D, Streissle G (1988) Chancen und Risiken durch Säugerzellkulturen. Forum Mikrobiol 11:359–367
- Petricciani JC (1987) The safe use of animal cells and their products. Swiss Biotechnol 5:13–18
Cited by
Coecke, S., Balls, M., Bowe, G., Davis, J., Gstraunthaler, G., Hartung, T., Hay, R., Merten, O.-W., Price, A., Schechtman, L., et al. (2005) · Alternatives to Laboratory Animals · doi:10.1177/026119290503300313 · Cited by 371
Good Cell Culture Practice for stem cells and stem-cell-derived models
Pamies, D. (2016) · ALTEX · doi:10.14573/altex.1607121 · Cited by 160
A Beginner’s Guide to Cell Culture: Practical Advice for Preventing Needless Problems
Weiskirchen, S., Schröder, S. K., Buhl, E. M., & Weiskirchen, R. (2023) · Cells · doi:10.3390/cells12050682 · Cited by 148
Guidance document on Good cell and tissue culture practice 2.0 (GCCP 2.0)
Pamies, D. (2021) · ALTEX · doi:10.14573/altex.2111011 · Cited by 100
Metadata
- Authors
- Frommer, W., Archer, L., Boon, B., Brunius, G., Collins, C. H., Crooy, P., Doblhoff-Dier, O., Donikian, R., Economidis, J., Frontali, C., Gaal, T., Hamp, S., Haymerle, H., Houwink, E. H., Küenzi, M. T., Krämer, P., Lelieveld, H. L. M., Logtenberg, M. T., Lupker, J., Lund, S., Mahler, J. L., Mosgaard, C., Normand-Plessier, F., Rudan, F., Simon, R., Tuijnenburg Muijs, G., Vranch, S. P., & Werner, R. G.
- Venue
- Applied Microbiology and Biotechnology
- Published
- 1993-05
- Volume
- 39
- Issue
- 2
- Pages
- 141-147
- ISSN
- 0175-7598
- 1432-0614
- Cited by
- 35
- References
- 8
- Language
- en
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.